The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary analysis of MUKDEN 01: A multicenter, single-arm, prospective, phase 2 study of neoadjuvant treatment with pyrotinib and letrozole plus dalpiciclib in triple-positive breast cancer.
 
Nan Niu
No Relationships to Disclose
 
Fang Qiu
No Relationships to Disclose
 
Tong Liu
No Relationships to Disclose
 
Wenbin Guo
No Relationships to Disclose
 
Guijin He
No Relationships to Disclose
 
Yi Zhao
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Dianlong Zhang
No Relationships to Disclose
 
Zhigao Li
No Relationships to Disclose
 
Peili Zhang
No Relationships to Disclose
 
Yuanxi Huang
No Relationships to Disclose
 
Gangling Zhang
No Relationships to Disclose
 
Ke Li
No Relationships to Disclose
 
Hongbin Han
No Relationships to Disclose
 
Zhengang Cai
No Relationships to Disclose
 
Pengfei Li
No Relationships to Disclose
 
Hong Xu
No Relationships to Disclose
 
Huajun Li
Employment - Jiangsu Hengrui Pharmaceuticals
 
Xinyu Zheng
No Relationships to Disclose
 
Caigang Liu
No Relationships to Disclose